- Home
- MCRB vs FCCO Comparison
MCRB vs FCCO Comparison
Compare MCRB & FCCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCRB
- FCCO
- Stock Information
- Founded
- MCRB 2010
- FCCO 1994
- Country
- MCRB United States
- FCCO United States
- Employees
- MCRB N/A
- FCCO N/A
- Industry
- MCRB Biotechnology: Pharmaceutical Preparations
- FCCO Major Banks
- Sector
- MCRB Health Care
- FCCO Finance
- Exchange
- MCRB Nasdaq
- FCCO Nasdaq
- Market Cap
- MCRB 142.0M
- FCCO 166.4M
- IPO Year
- MCRB 2015
- FCCO 1998
- Fundamental
- Price
- MCRB $0.85
- FCCO $20.90
- Analyst Decision
- MCRB Buy
- FCCO Buy
- Analyst Count
- MCRB 4
- FCCO 1
- Target Price
- MCRB $4.17
- FCCO $21.00
- AVG Volume (30 Days)
- MCRB 5.4M
- FCCO 13.0K
- Earning Date
- MCRB 10-31-2024
- FCCO 10-16-2024
- Dividend Yield
- MCRB N/A
- FCCO 2.87%
- EPS Growth
- MCRB N/A
- FCCO N/A
- EPS
- MCRB N/A
- FCCO 1.42
- Revenue
- MCRB $374,000.00
- FCCO $59,227,000.00
- Revenue This Year
- MCRB N/A
- FCCO N/A
- Revenue Next Year
- MCRB N/A
- FCCO $9.86
- P/E Ratio
- MCRB N/A
- FCCO $14.72
- Revenue Growth
- MCRB N/A
- FCCO N/A
- 52 Week Low
- MCRB $0.54
- FCCO $15.40
- 52 Week High
- MCRB $2.06
- FCCO $23.30
- Technical
- Relative Strength Index (RSI)
- MCRB 42.22
- FCCO 42.85
- Support Level
- MCRB $0.80
- FCCO $20.49
- Resistance Level
- MCRB $1.07
- FCCO $21.81
- Average True Range (ATR)
- MCRB 0.12
- FCCO 0.64
- MACD
- MCRB -0.02
- FCCO -0.15
- Stochastic Oscillator
- MCRB 12.26
- FCCO 17.30
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.
About FCCO First Community Corporation
First Community Corp is a bank holding company, which provides commercial banking services. It is engaged in the general commercial and retail banking business characterized by personalized service and local decision making, emphasizing the banking needs of small to medium-sized businesses, professional concerns, and individuals. It operates through following segments: Commercial and Retail Banking; Mortgage Banking; Investment Advisory and Non-Deposit; and Corporate. It offers checking, savings, money market, individual retirement, and certificates of deposit accounts. Its lending lines include consumer loans, real estate loans, home improvement loans, home loans, flex loans, construction loans, agricultural loans, and others.